What is the ticker symbol for Keros Therapeutics?

Keros Therapeutics trades under the ticker KROS on NASDAQ.

What sector does Keros Therapeutics operate in?

Keros Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze KROS in a portfolio?

PortView shows KROS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Keros Therapeutics (KROS) Stock Analysis

NASDAQHealthcareBiotechnology

$11.03-0.41%

1-year price historyRange $9.91 – $21.84

52-week range$11.03

$9.69$22.55

What Keros Therapeutics does

Keros Therapeutics, Inc., a biopharmaceutical entity in the clinical development phase, is focused on pioneering and commercializing innovative therapies for individuals afflicted by hematological and musculoskeletal conditions that currently lack adequate treatment options. Its flagship protein therapeutic, KER-050, is being advanced to address diminished blood cell counts (cytopenias), specifically anemia and thrombocytopenia, in patients diagnosed with myelodysplastic syndromes and myelofibrosis. Furthermore, the company is progressing KER-047, a small molecule designed to combat anemia, which is presently undergoing Phase 1 clinical evaluation. Another small molecule, KER-012, is also in Phase 1 clinical trials for treating ailments characterized by bone degeneration, such as osteoporosis and osteogenesis imperfecta, alongside pulmonary arterial hypertension. Founded in 2015, the firm maintains its principal operations in Lexington, Massachusetts.

Key metrics

Market cap

$352.78M

P/E (TTM)

-2.98

EPS (TTM)

$-3.70

Beta

1.01

Dividend yield

0.00%

Revenue / share

$0.76

50-day avg

$10.78

200-day avg

$13.74

52-week high

$22.55

52-week low

$9.69

CEO

Jasbir S. Seehra

ETFs linked to KROS

Broad-market and Healthcare sector ETFs an investor holding Keros Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how KROS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze KROS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Keros Therapeutics?: Keros Therapeutics trades under the ticker KROS on NASDAQ.
Which exchange is KROS listed on?: KROS is listed on NASDAQ.
What sector does Keros Therapeutics operate in?: Keros Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze KROS in a portfolio?: PortView shows KROS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.